Skip to main content
OpenTrials
Completed

NCT Number: NCT02379702

Metabolic Syndrome Prevalence Study

Following the first study conducted to investigate the prevalence of metabolic syndrome and its components in Turkey, it was aimed to demonstrate the change in general health condition of available patients after the period of time lapsed. This study will provide important information on the social and economic dimensions of metabolic syndrome and will contribute to development of preventive programs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Syndrome Glucose Metabolism Disorders Hyperinsulinism Insulin Resistance Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara University, Ankara, Turkey (Türkiye)

Loading trial locations.

About this study

In the first METSAR-I study conducted in 2003, metabolic syndrome screening was made by two different team. Participants were visited at their addresses and informed about the research study and gave written consent. They were invited on an empty stomach for hospital visit on the day after. Pre-trained nurses completed the forms of patients during that second visit. After 11 years, a questionnaire by telephone survey will be applied to patients who participated in the METSAR-II study. The main goal is to determine the changes of metabolic syndrome population during that period.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Volunteers who participated in the METSAR-I study in 2003
  • Patients who accepted to participate will be included the second follow up phase.

Exclusion criteria

None

Treatment and study plan

Metabolic Syndrome

Other

This study will provide important information on the social and economic dimensions of metabolic syndrome

Primary outcomes

  1. comorbidities and changes in general health

    Time frame: 10 year

Sponsors and collaborators

Lead sponsor

Abdi Ibrahim Ilac San. ve Tic A.S.

Industry

Registry information

Official study title

Turkey Metabolic Syndrome Prevalence Study - METSAR II

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Mar 5, 2015
Registry last updated
Mar 5, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.